This page contains recent news articles, when available, and an overview of but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Background information on

Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in ...  -  25 Mar 2008
PR Newswire (press release),A new chemical compound for the treatment of non- Hodgkin's lymphoma (NHL), and various other hematologic malignancies, solid tumors, and immunological

3Com Advances In Pre-Market After Reporting Q3 Financial Results ...  -  25 Mar 2008
RTT News,The EXTEND clinical trial is a phase III single agent trial of pixantrone for patients with relapsed, aggressive non-Hodgkin's lymphoma who received two or

Micromet Establishes New Scientific Advisory Board for Its BiTE ...  -  25 Mar 2008
CNNMoney.com (press release)...the treatment of patients with acute lymphoblastic leukemia, and in a phase 1 clinical trial for the treatment of patients with non-Hodgkin's lymphoma.

DJ HUGIN NEWS/Micromet Establishes New Scientific -2-  -  25 Mar 2008
VisAvis (Pressemitteilung),...the treatment of patients with acute lymphoblastic leukemia, and in a phase 1 clinical trial for the treatment of patients with non-Hodgkin's lymphoma.

Ottawa philanthropist donates $11 million to cancer care in ...  -  25 Mar 2008
The Canadian Press,Irving Greenberg chaired the Queensway Carleton Hospital's first capital expansion campaign before he died of non-Hodgkin's lymphoma more than 20 years ago.

Chris Bliss, Robert Schimmel and more: Laugh Track for March 28-30  -  25 Mar 2008
The Plain Dealer - cleveland.com,He survived non Hodgkin's lymphoma in 2000, managing to laugh through the treatment, such as his "Sharon Stone moment" with a hospital gown.

State: Zero rise in cancer cases  -  25 Mar 2008
Concord Monitor,Bernier has since moved to Wilmot, where he was diagnosed with non-Hodgkin's lymphoma three years ago. His family's experience demonstrates shortcomings in

Accentia Biopharmaceuticals Announces  -  25 Mar 2008
Ad-Hoc-News (Pressemitteilung),Phase 3 clinical trial for BiovaxID which is a patient-specific anti-cancer vaccine focusing on the treatment of follicular non-Hodgkin's lymphoma.

Patients With Non-Hodgkin's Lymphoma Have Shown Improved Outlook ...  -  Mar 21, 2008
Medical News Today,Non-Hodgkin's lymphoma is a set of different cancers of the lymphocytes in the immune system, and they can affect any of the organs related to the lymph

Zevalin® Receives Positive CHMP Opinion In Europe For First Line ...  -  Mar 24, 2008
Medical News Today (press release),Zevalin is currently approved for adult patients with rituximab relapsed or refractory CD20-positive follicular B-cell Non-Hodgkin's Lymphoma (NHL) in

Western Michigan's Murray battling Hodgkin's lymphoma  -  Mar 20, 2008
MLive.com,..."It could have been non-Hodgkin's lymphoma," Murray said of the more advanced cancer. "This is 90-to 100-percent curable. ... I'm kind of nervous but I'm

Non-Hodgkin's cancer patients living longer: study  -  Mar 10, 2008
ReutersCHICAGO (Reuters) - Improved treatments for non-Hodgkin's lymphoma helped patients live longer in the United States, researchers said on Monday.

Hepatitis C: a risk factor for lymphoma  -  Feb 26, 2008
ReutersIn 2.4 percent of the patients with non-Hodgkin's lymphoma were also infected with HCV compared with 0.7 percent of the comparison subjects.

Magnesium May Lower Stroke, Glaucoma May Raise Cardiovascular ...  -  Mar 10, 2008
Insider Medicine,From Germany - Data from the Surveillance, Epidemiology and End Results Program were analyzed and showed that 5 year survival from Non-Hodgkin's lymphoma

Immunomedics, Inc. (IMMU)'s Milatuzumab receives FDA orphan drug ...  -  Mar 19, 2008
Checkbiotech.org (press release),We have initiated Phase I/II studies to evaluate the therapeutic potential of milatuzumab in patients with multiple myeloma, non-Hodgkin's lymphoma (NHL)

Non-Hodgkin lymphoma patients living longer  -  Mar 10, 2008
CTV.ca,In particular, a key weapon against non-Hodgkin's lymphoma is the antibody therapy rituximab, sold under the brand name Rituxan in Canada and approved by

Immunomedics Develops New Immunoconjugates for Targeted ...  -  Mar 20, 2008
Primenewswire (press release),We have six potential oncology therapeutics in clinical trials: epratuzumab and 90Y-epratuzumab in non-Hodgkin's lymphoma (NHL) and acute lymphoblastic

Allos Therapeutics Reports 2007 Results  -  Feb 27, 2008
FOXBusinessInitiated a Phase 1, open-label, multi-center dose escalation study of RH1 in patients with advanced solid tumors or non-Hodgkin's lymphoma (NHL).

Updated NICE Guideline Recommends Rituximab for Follicular Lymphoma  -  Feb 28, 2008
DG News...in combination with chemotherapy, as an option for inducing remission in people with relapsed stage III or IV follicular non-Hodgkin's lymphoma.

Cephalon Could Turn Tide If Cancer Drug Is Approved  -  Mar 19, 2008
Wall Street Journal...that he said could prove conservative if Treanda is used extensively off-label in later-stage CLL or earlier-stage persistent non-Hodgkin's lymphoma.

EU agency backs new use of Bayer's drug Zevalin  -  Mar 20, 2008
ReutersThe medicine is currently authorised for patients with follicular B-cell non-Hodgkin's lymphoma, in combination with rituximab.

Genitope halts MyVax work San Francisco Business Times  -  Mar 10, 2008
Bizjournals.com,Genitope Corp. said it will suspend work on its cornerstone personalized cancer vaccine, MyVax, for folliculr non-Hodgkin's lymphoma.

Cell Therapeutics's combination therapy found effective against ...  -  Mar 20, 2008
Pharmaceutical Business ReviewBy Staff Writer A total of 61 patients with advanced (stage III-IV) follicular non-Hodgkin's lymphoma (NHL) were treated with six cycles of fludarabine and

Fludarabine, Mitoxantrone and Zevalin(R) Produces 96% Complete ...  -  Mar 16, 2008
PR Newswire (press release),MTA) today announced that patients with previously untreated follicular non-Hodgkin's lymphoma (NHL) treated with fludarabine and mitoxantrone,

Non-AIDS-defining cancers now outweigh AIDS-defining cancers in US ...  -  Feb 27, 2008
Aidsmap,There are currently three in the United States: Kaposi's sarcoma, non-Hodgkin's lymphoma, and cervical cancer. Many earlier studies have shown markedly

Capt. Benjamin C. Jarvis dies - sub skipper  -  Mar 22, 2008
San Francisco Chronicle,The cause of death, his family said, was non-Hodgkin's lymphoma. Capt. Jarvis was a member of a family that traced its roots back to an ancestor who landed

Committee for Medicinal Products for Human Use Post-authorisation ...  -  Mar 21, 2008
PharmaLive.com (press release),Zevalin is indicated for the treatment of adult patients with rituximab relapsed or refractory CD20+ follicular B-cell non-Hodgkin's lymphoma (NHL).

DJ HUGIN NEWS/Micromet Announces Presentation of -2-  -  Mar 19, 2008
VisAvis (Pressemitteilung),...the treatment of patients with acute lymphoblastic leukemia and in a phase 1 clinical trial for the treatment of patients with non-Hodgkin's lymphoma.

Pixantrone to be studied in phase I/II trial for aaggressive ...  -  Mar 7, 2008
Checkbiotech.org (press release),A phase III trial with pixantrone in relapsed aggressive non-Hodgkin's lymphoma (NHL) is near completion. "Despite the availability of newer biologic agents

Genitope to cut jobs, seek MyVax approval overseas  -  Mar 14, 2008
Bizjournals.com,MyVax failed in a 287-person Phase III trial to show it could halt the progression of one of the 30 types of non-Hodgkin's lymphoma, which collectively

Victim's kin backs flame-retardant ban  -  Mar 7, 2008
Los Angeles Times,Dioxins have been associated with non-Hodgkin's lymphoma. "Chemicals killed her," said James Golden, the firefighter's father. "These fire retardants in

Local Man is Proof Anti-Body Treatment Works in Lymphoma Patients  -  Mar 11, 2008
WREX-TV,ROCKFORD - Patients diagnosed with non-Hodgkin's lymphoma get some good news from a German study. It says they have a better chance at the beating the

Micromet, Inc. Reports Fourth Quarter and Full Year 2007 Financial ...  -  Mar 13, 2008
MSN Money...for MT103 in late-stage non-Hodgkin's lymphoma patients and completing preclinical development of MT110, our first BiTE antibody targeting solid tumors.

Cephalon wins US approval for leukemia drug  -  Mar 20, 2008
ReutersIt also is under FDA review for a type of non-Hodgkin's lymphoma. The company said it expects Treanda to be available for US physicians and patients in

Cephalon gets FDA OK for Treanda  -  Mar 20, 2008
Bizjournals.com,Cephalon has also filed a new drug application for Treanda as a treatment for patients with non-Hodgkin's lymphoma. A decision on that application is

LOCAL AND STATE NEWS  -  Mar 11, 2008
San Jose Mercury News,Genitope halted development of its experimental MyVax treatment for non-Hodgkin's lymphoma after US regulators said at least one more clinical trial was

Chronic Lymphocytic Leukemia drug from Cephalon receives FDA approval  -  Mar 21, 2008
Checkbiotech.org (press release),In December 2007, Cephalon submitted an NDA requesting approval of TREANDA for the treatment of patients with indolent (slow-growing) non-Hodgkin's lymphoma

Protopic suit refiled in St. Clair County  -  Feb 25, 2008
Madison County Record,John Lancaster of St. Louis also is listed as a plaintiff claiming he developed non-Hodgkin's lymphoma after using the product for a year.

Micromet Announces Presentation of  -  Mar 19, 2008
Ad-Hoc-News (Pressemitteilung),...for the treatment of patients with acute lymphoblasticleukemia and in a phase 1 clinical trial for the treatment ofpatients with non-Hodgkin's lymphoma.

Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended ...  -  Mar 13, 2008
Earthtimes,...began clinical evaluation of TRU-015 in non-Hodgkin's lymphoma (NHL) and expect to do the same in systemic lupus erythematosus (SLE) later this year.

Immunomedics gets FDA orphan drug designation for milatuzumab  -  Mar 18, 2008
CNNMoney.com...to evaluate the 'therapeutic potential' of milatuzumab in patients with multiple myeloma, non-Hodgkin's lymphoma and chronic lymphocytic leukemia.

Two girls in doorway help photographer win contest  -  Mar 21, 2008
Elmira Star-Gazette,Brianna Lurcock-Timmerman, 13, has non-Hodgkin's lymphoma and other serious health problems. She travels frequently to Golisano Children's Hospital in

FDA OKs Cephalon drug  -  Mar 21, 2008
Trading Markets (press release),Baldino said Cephalon also was seeking FDA approval to market Treanda for patients with relapsed indolent non-Hodgkin's lymphoma and expected a decision in

First 5 Director Steps Down  -  Mar 18, 2008
TurnTo23.com,First 5 Kern's executive director has stepped down temporarily after being diagnosed with non-Hodgkin's lymphoma. Wendy Wayne was hired during the summer of

Minnesota girl injured by pool drain dies  -  Mar 21, 2008
Omaha World-Herald (subscription),...evolved into tumors, one of her doctors said earlier this month. If left untreated, the tumors could turn into non-Hodgkin's lymphoma, a form of cancer.

Targeted Therapies: A New Generation of Cancer Treatments  -  Mar 6, 2008
RedOrbit,For instance, non small cell lung cancer and non-Hodgkin's lymphoma primarily affect elderly patients, many of whom have medical comorbidities that limit

Genitope Corporation To Suspend Development Of MyVax(R ...  -  Mar 12, 2008
Medical News Today (press release),..."We are disappointed that we will not be able to make MyVax® personalized immunotherapy available to patients with follicular non-Hodgkin's lymphoma," said

Cancer survivor’s marathon goal  -  Mar 11, 2008
This is Local London,But, after successful treatment for non-Hodgkin's lymphoma, he is now in remission. He is now determined to complete his goal of running 10 marathons - and

NICE Approves MabThera(R) (Rituximab) As Maintenance Therapy For ...  -  Feb 28, 2008
Medical News Today (press release),Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non- Hodgkin's lymphoma, both in patients with and without rituximab during

Cancer therapy failure has Genitope hope on the ropes  -  Mar 21, 2008
San Jose Business Journal (Subscription),MyVax failed in a 287-person Phase III trial to show it could halt the progression of one of the 30 types of non-Hodgkin's lymphoma, which collectively

Search the web for more resources on

Web health.mongabay.com

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.